UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

 

(Amendment No. )*

 

 

Achieve Life Sciences, Inc.
(Name of Issuer)
 
Common Stock, par value $0.001
(Title of Class of Securities)
 
004468500
(CUSIP Number)
 
December 24, 2020
(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

o Rule 13d-1(b)
x Rule 13d-1(c)
o Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

 

CUSIP No. 004468500 13G Page 1 of 9 Pages

 

 

 

1.

 

NAME OF REPORTING PERSONS

Catalysis Partners, LLC

 

 

2.

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

(a)     o

(b)     o

 

 

3.

 

SEC USE ONLY

 

 

4.

 

 

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH

 

5.

 

SOLE VOTING POWER

0

 

 

6.

 

SHARED VOTING POWER

307,000

 

 

7.

 

SOLE DISPOSITIVE POWER

0

 

 

8.

 

 

SHARED DISPOSITIVE POWER

307,000

 

 

 

9.

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

307,000

 

 

10.

 

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

(SEE INSTRUCTIONS)

o

 

 

11.

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

5.0% (See Note 1)

 

 

12.

 

 

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

PN

 

       

(1) Based on 6,088,914 outstanding shares of Common Stock (as defined below) as of December 4, 2020, as represented by the Issuer in the Form 424B4 filed with the Securities and Exchange Commission on December 4, 2020. The number of outstanding shares includes full exercise of the underwriter's option to purchase additional shares in the offering described in the Prospectus.

 

 

CUSIP No. 004468500 13G Page 2 of 9 Pages

 

 

 

1.

 

NAME OF REPORTING PERSONS

Francis Capital Management, LLC

 

 

2.

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

(a)     o

(b)     o

 

 

3.

 

SEC USE ONLY

 

 

4.

 

 

CITIZENSHIP OR PLACE OF ORGANIZATION

California

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH

 

5.

 

SOLE VOTING POWER

0

 

 

6.

 

SHARED VOTING POWER

307,000

 

 

7.

 

SOLE DISPOSITIVE POWER

0

 

 

8.

 

 

SHARED DISPOSITIVE POWER

307,000

 

 

 

 

9.

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

307,000

 

 

10.

 

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

(SEE INSTRUCTIONS)

o

 

 

11.

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

5.0% (See Note 2)

 

 

12.

 

 

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

IA, OO, HC

 

       

(2) See Note (1) Above

 

CUSIP No. 004468500 13G Page 3 of 9 Pages

 

 

 

1.

 

NAME OF REPORTING PERSONS

John Francis

 

 

2.

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

(a)     o

(b)     o

 

 

3.

 

SEC USE ONLY

 

 

4.

 

 

CITIZENSHIP OR PLACE OF ORGANIZATION

United States

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH

 

5.

 

SOLE VOTING POWER

22,150

 

 

6.

 

SHARED VOTING POWER

319,000 (See Note 3)

 

 

7.

 

SOLE DISPOSITIVE POWER

22,150

 

 

8.

 

 

SHARED DISPOSITIVE POWER

319,000 (See Note 3)

 

 

 

 

9.

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

341,150

 

 

10.

 

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

(SEE INSTRUCTIONS)

o

 

 

11.

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

5.6% (See Note 4)

 

 

12.

 

 

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

IN, HC

 

       

(3) John Francis and his wife hold 12,000 shares jointly and John Francis shares voting and dispositive power of the shares.

(4) See Note (1) Above

 

CUSIP No. 004468500 13G Page 4 of 9 Pages

 

 

Item 1(a).

Name of Issuer:

 

 

Achieve Life Sciences, Inc. (the “Issuer”)

 

Item 1(b).

Address of Issuer’s Principal Executive Offices:

 

  1040 West Georgia, Suite 1030
 

Vancouver, British Columbia, V6E 4H1

 

Item 2(a).

Name of Persons Filing:

 

 

This statement is filed by the entities and persons listed below, who are

collectively referred to herein as "Reporting Persons", with respect to the

shares of Common Stock (as defined in Item 2(d) below) of the Company:

 

(i)                Catalysis Partners, LLC

 

(ii)               Francis Capital Management, LLC

 

(iii)              Mr. John Francis

 

Item 2(b).

Address of Principal Business Office or, if none, Residence:

 

 

(i)           Catalysis Partners, LLC

610 Main Street

Venice, CA 90291

 

(ii)          Francis Capital Management, LLC

610 Main Street

Venice, CA 90291

 

(iii)         Mr. John Francis

c/o Francis Capital Management, LLC

610 Main Street

Venice, CA 90291

 

Item 2(c).

Citizenship:

 

 

(i)                Catalysis Partners, LLC – DE

 

(ii)               Francis Capital Management, LLC – CA

 

(iii)              Mr. John Francis – USA

 

Item 2(d). Title of Class of Securities:
  Common stock, par value $0.001 (“Common Stock”)
Item 2(e). CUSIP Number:
  004468500
Item 3.

If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

 

Not Applicable

 

 

CUSIP No. 004468500 13G Page 5 of 9 Pages

 

 

Item 4.   Ownership
  (i) Catalysis Partners, LLC
  (a) Amount beneficially owned:  307,000 (See Note 5)
  (b) Percent of class: 5.0% (See Note 6)
  (c) Number of shares as to which the person has:
    (i) Sole power to vote or to direct the vote: 0
    (ii) Shared power to vote or to direct the vote: 307,000 (See Note 5)
    (iii) Sole power to dispose or to direct the disposition of: 0
    (iv) Shared power to dispose or to direct the disposition of: 307,000 (See Note 5)
  (ii) Francis Capital Management, LLC  
  (a)       Amount beneficially owned: 307,000 (See Note 5)
  (b) Percent of class: 5.0% (See Note 6)
  (c) Number of shares as to which the person has:
  (i) Sole power to vote or to direct the vote: 0
  (ii) Shared power to vote or to direct the vote: 307,000 (See Note 5)
  (iii) Sole power to dispose or to direct the disposition of: 0
  (iv) Shared power to dispose or to direct the disposition of: 307,000 (See Note 5)
  (iii) John Francis
  (a) Amount beneficially owned: 341,150 (See Note 5)
  (b) Percent of class: 5.6% (See Note 6)
  (c) Number of shares as to which the person has:
  (i) Sole power to vote or to direct the vote: 22,150
  (ii) Shared power to vote or to direct the vote: 319,000 (See Note 5)
  (iii) Sole power to dispose or to direct the disposition of: 22,150
  (iv) Shared power to dispose or to direct the disposition of: 319,000 (See Note 5)
               
CUSIP No. 004468500 13G Page 6 of 9 Pages

 

 

Note 5:  

 

Francis Capital Management, LLC is an investment advisor that is registered under the Investment Advisors Act of 1940. Francis Capital Management, LLC, which serves as the general partner and investment manager to Catalysis Partners, LLC, (the "Fund"), may be deemed to be the beneficial owner of all shares of Common Stock held by the Fund. Mr. John Francis, as Managing Member of Francis Capital Management, LLC, with the power to exercise investment and voting discretion, may be deemed to be the beneficial owner of all shares of Common Stock held by the Fund.      

 

Note 6:  

 

Based on 6,088,914 outstanding shares of Common Stock as of December 4, 2020, as represented by the Issuer in the Form 424B4 filed with the Securities and Exchange Commission on December 4, 2020. The number of outstanding shares includes full exercise of the underwriter's option to purchase additional shares in the offering described in the Prospectus.        

 

Item 5.

Ownership of Five Percent or Less of a Class:

 

Not Applicable

 

Item 6.

Ownership of More Than Five Percent on Behalf of Another Person:

 

  See Note 5 above. The Fund has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock covered by this Statement.
Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company:

 

  Not Applicable
Item 8. Identification and Classification of Members of the Group:
 

 

Not Applicable

 

Item 9. Notice of Dissolution of Group:
 

 

Not Applicable

   
CUSIP No. 004468500 13G Page 7 of 9 Pages

 

 

Item 10. Certifications:
 

 

Each of the Reporting Persons makes the following certification:

 

By signing below each Reporting Person certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. After reasonable inquiry and to the best of my knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

 

 

Date: January 7, 2021

 

 

CATALYSIS PARTNERS, LLC

By: Francis Capital Management, LLC, its General Partner

By: /s/ John Francis

Name: John Francis

Title: Managing Member

 

 

FRANCIS CAPITAL MANAGEMENT, LLC

By: /s/ John Francis

Name: John Francis

Title: Managing Member

 

John Francis

By: /s/ John Francis

 

CUSIP No. 004468500 13G Page 8 of 9 Pages

 

 

EXHIBIT A

 

Joint Filing Agreement Pursuant to Rule 13d-1

 

This agreement is made pursuant to Rule 13d-l(k)(1) under the Securities Exchange Act of 1934, as amended (the "Act") by and among the parties listed below, each referenced to herein as a "Joint Filer". The Joint Filers agree that a statement of beneficial ownership as required by Sections 13(g) or 13(d) of the Act and the rules thereunder may be filed on each of his, her or its behalf on Schedule 13G or Schedule 13D, as appropriate, and that said joint filing may thereafter be amended by further joint filings. The Joint Filers state that they each satisfy the requirements for making a joint filing under Rule 13d-1(k).

 

 

Dated:  January 7, 2021
     

CATALYSIS PARTNERS, LLC

By: Francis Capital Management, LLC, its General Partner

By: /s/ John Francis

Name: John Francis

Title: Managing Member

 

 

FRANCIS CAPITAL MANAGEMENT, LLC

By: /s/ John Francis

Name: John Francis

Title: Managing Member

 

John Francis

By: /s/ John Francis

 

CUSIP No. 004468500 13G Page 9 of 9 Pages